non-small cell lung cancer

AbbVie pairs up another ADC cancer drug with Bristol-Myers Squibb's Opdivo
Fierce Biotech
Sat, 09/23/17 - 10:02 am
AbbVie
Bristol-Myers Squibb
Opdivo
ABBV-399
antibody-drug conjugate
non-small cell lung cancer
Merck's new Keytruda flat dose could add $1B each year to U.S. healthcare spending
Fierce Pharma
Mon, 07/17/17 - 06:49 pm
Merck
Keytruda
drug pricing
non-small cell lung cancer
FDA approves diagnostic that simultaneously screens for multiple cancer biomarkers
Drug Delivery Business News
Sat, 06/24/17 - 09:07 am
FDA
Thermofisher
diagnostics
biomarkers
non-small cell lung cancer
Oncomine Dx Target Test
Novartis picks up FDA approval for targeted lung cancer meds Tafinlar, Mekinist
Fierce Pharma
Fri, 06/23/17 - 03:35 pm
Novartis
FDA
Tafinlar
Mekinist
non-small cell lung cancer
BRAF V600
Incyte keeps the ASCO spotlight focused on its closely-watched IDO1 drug epacadostat
Endpoints
Mon, 06/5/17 - 10:08 am
Incyte
ASCO 2017
epacadostat
non-small cell lung cancer
Keytruda
Novartis' Zykadia piles pressure on Pfizer's Xalkori, Roche's Alecensa with new lung cancer nod
Fierce Pharma
Wed, 05/31/17 - 09:32 am
Novartis
Zykadia
Pfizer
Xalkori
Roche
Alecensa
non-small cell lung cancer
Incyte gets a boost from a series of positive data snapshots for its epacadostat/Keytruda combo
Endpoints
Thu, 05/18/17 - 12:08 am
Incyte
epacadostat
ASCO 2017
Merck
Keytruda
non-small cell lung cancer
Syndax shares soar as lead drug clears a mid-stage cancer drug study hurdle
Endpoints
Thu, 05/18/17 - 12:02 am
Syndax Pharma
clinical trials
entinostat
non-small cell lung cancer
Astellas scraps NSCLC program after look at phase 3 data
Fierce Biotech
Fri, 05/12/17 - 11:47 am
Astellas
non-small cell lung cancer
clinical trials
ASP8273
AstraZeneca’s shares spike on positive PhIII lung cancer data — but it’s not MYSTIC
Endpoints
Fri, 05/12/17 - 09:40 am
AstraZeneca
clinical trials
durvalumab
Imfinzi
non-small cell lung cancer
Has Merck Lucked Into A $10 Billion Drug?
Forbes
Thu, 05/11/17 - 11:20 am
Merck
Keytruda
bladder cancer
non-small cell lung cancer
OncoMed racks up three straight clinical disasters as lead drug implodes
Endpoints
Mon, 05/8/17 - 10:02 pm
OncoMed
demcizumab
Celgene
clinical trials
non-small cell lung cancer
Roche unit Genentech takes on Pfizer with new lung cancer data
BioPharma Dive
Mon, 04/10/17 - 11:10 am
Roche
Genentech
Pfizer
Xalkori
Alecensa
non-small cell lung cancer
Racing in lung cancer again (or still), Merck and BMS expand Incyte combo trials
Fierce Pharma
Tue, 04/4/17 - 11:10 pm
Merck
Bristol-Myers Squibb
Incyte
Keytruda
Opdivo
non-small cell lung cancer
FDA Approves Astra's Lung Cancer Drug
Investopedia
Fri, 03/31/17 - 10:09 pm
AstraZeneca
FDA
Tagrisso
non-small cell lung cancer
AstraZeneca’s Lung Cancer Drug Secures China Approval
Investopedia
Mon, 03/27/17 - 09:38 am
AstraZeneca
China
Tagrisso
non-small cell lung cancer
Struggling Heat gets a warm response to a snapshot on cancer vax data
Endpoints
Tue, 03/21/17 - 10:06 am
Heat Biologics
vaccines
HS-110
non-small cell lung cancer
Bristol-Myers Squibb
Opdivo
Pfizer, Merck KGaA Delay Lung Cancer Drug Trial Outcome
Investopedia
Mon, 03/20/17 - 10:54 am
Pfizer
Merck KGaA
clinical trials
avelumab
non-small cell lung cancer
The FDA opens an inside track to let Novartis race ahead on Zykadia as Roche rivalry heats up
Endpoints
Thu, 02/23/17 - 09:23 am
FDA
Novartis
Zykadia
ALK-positive non-small cell lung cancer
non-small cell lung cancer
Roche
Alecensa
Roche cancer drug taking bite out of Bristol's Opdivo
Yahoo/Reuters
Fri, 01/27/17 - 09:23 am
Roche
Bristol-Myers Squibb
Tecentriq
non-small cell lung cancer
Opdivo

Pages